When you apply for private health insurance outside the ACA marketplace, the carrier is going to pull your prescription history. Understanding how private health insurance underwriting works starts here: the Rx pull is one of the most data-rich inputs available to an underwriter, and it shapes decisions on acceptability, premium classification, and any condition-specific riders or exclusions that appear on your policy.
This piece explains what the report contains, how underwriters interpret what they see, and what it means practically for someone with medications on record — whether straightforward or complex.
The two primary services used by carriers are Milliman IntelliScript and ScriptCheck (also operated by Milliman). When you sign the consent-to-disclose language on an insurance application, you authorize the carrier to pull a report containing every prescription filled under your name at participating pharmacies over the past 5–10 years.
The data comes from pharmacy benefit manager (PBM) records — the intermediaries that process insurance-billed transactions at chain pharmacies, mail-order fulfillment services, and most independent pharmacies that accept insurance. Cash-pay prescriptions at independent pharmacies that don't run a benefits claim may not appear, but anything processed through insurance almost certainly will.
What the report contains for each prescription:
The carrier does not receive a diagnosis directly from this report. What it receives is a medication list. Underwriters are trained — and underwriting systems are programmed — to infer clinical conditions from prescribing patterns with consistent accuracy.
Looking at private health plan options
Underwriters and their automated systems map medications to probable clinical conditions as a matter of routine. The inferences are well-established and consistently applied across the industry. Common medication-to-condition mappings include:
Metformin → type 2 diabetes (the most common first-line inference)
GLP-1 agonists (semaglutide, tirzepatide) → diabetes management or chronic weight management
Statins (atorvastatin, rosuvastatin, simvastatin) → hyperlipidemia; combined with antihypertensives, signals a cardiovascular risk profile
ACE inhibitors or ARBs (lisinopril, losartan) → hypertension
SSRIs and SNRIs (sertraline, escitalopram, duloxetine) → depression, anxiety, or both
Levothyroxine → hypothyroidism
Inhaled corticosteroids or bronchodilators (fluticasone, albuterol) → asthma or COPD
Anticoagulants (warfarin, apixaban) → atrial fibrillation or prior clot event
A single medication on this list does not automatically disqualify an applicant. What matters is the full picture: how long the condition has been treated, whether it appears controlled (stable dosing, no recent changes), whether multiple related medications suggest a more complex clinical profile, and how recently any regimen changes occurred.
The distinction underwriters draw most consistently is between conditions that are controlled on stable medication and those that are not. A person who has filled the same dose of lisinopril for six years for mild hypertension — with nothing else in the cardiovascular medication category — presents a fundamentally different risk profile than someone who has cycled through three antihypertensives in 18 months and recently added a diuretic.
Conditions that are generally acceptable under underwritten plans, often with a waiting period:
Conditions that draw closer scrutiny and a higher frequency of exclusions or declines:
If your Rx history falls into the second category, understanding how pre-existing condition waiting periods work in underwritten plans is essential before you apply — the structure of your application can affect whether a condition is excluded or included with a waiting period.
Ozempic (semaglutide), Wegovy (semaglutide), and Mounjaro/Zepbound (tirzepatide) are now among the most prescribed medications in the country, and underwriters are paying markedly closer attention to them in 2026 applications. The challenge is that these drugs are FDA-approved for two distinct indications — type 2 diabetes management and chronic weight management — and the implications for underwriting differ meaningfully.
A GLP-1 prescribed for weight management in an otherwise healthy applicant with no other metabolic medications is a different risk signal than a GLP-1 prescribed as part of a diabetes treatment protocol that also includes metformin and an ACE inhibitor.
If you are taking a GLP-1 medication, expect the underwriter to want to know:
Be prepared to provide a clear, accurate answer on the application and, if requested, supplemental records from the prescribing physician. Do not leave the prescribing indication ambiguous. An unclear application on a GLP-1 is more likely to trigger a full medical records request than a clear one — which slows the process and can result in a worse underwriting outcome.
If the prescription history report reveals a medication that contradicts your application responses — you answered "no" to a diabetes question but the report shows two years of continuous metformin refills — the carrier has grounds to rescind your policy. Rescission means coverage is voided retroactively from the issue date, and claims that were paid may be recouped. This can happen after you have paid months or years of premiums, and it can happen after a significant claim has already been filed.
Honest disclosure does not guarantee acceptance, but it eliminates rescission risk entirely. If you are accepted with a pre-existing condition excluded under a waiting period, the worst outcome is a period during which that specific condition isn't covered. A rescission is categorically more damaging. There is no upside to non-disclosure — only the illusion of one.
For someone with no chronic medications and no prescriptions in the past several years suggesting an ongoing condition, the Rx pull is a formality. Underwriting typically proceeds quickly, and approval is likely if health questionnaire responses are consistent with the report. This is the profile that makes private health insurance a strong fit for healthy Florida adults — underwriting is straightforward, and the resulting premium reflects a clean risk profile.
For someone with a more complex Rx history, the pull is the beginning of a more detailed review process. You may be asked to provide attending physician statements, authorize release of medical records, or complete supplemental health questionnaires. This is standard for any application with clinical complexity — it is not automatically a denial signal. It is an information-gathering step.
Working with a licensed producer before you apply means your application is structured accurately and completely. Producers who work regularly with underwritten private plans know which conditions typically result in approval with a waiting period, which require supplemental documentation, and which are likely to result in a decline — at which point the ACA marketplace is the appropriate recommendation.
For additional context on coverage options in Florida, Florida Plan Finder covers the full landscape of Florida health insurance including marketplace and private plan comparisons.
ACA marketplace plans are guaranteed-issue: carriers cannot ask about your health history, decline you based on medical conditions, or apply pre-existing condition exclusions or waiting periods. If your prescription history includes conditions that underwritten plans routinely exclude or decline outright — uncontrolled or recently diagnosed diabetes, recent cardiac events, active cancer treatment, or significant organ-system complexity — the ACA marketplace is the appropriate product.
The financial trade-off for guaranteed-issue coverage is cost: an unsubsidized Florida ACA Bronze HMO in 2026 typically runs $300–$550 per month for a healthy adult in their 30s, with a $7,000–$10,000 deductible. If you receive a meaningful APTC subsidy based on income, the ACA may be the right financial choice regardless of health history. For those who don't qualify for subsidies and who can pass underwriting, private plans frequently deliver comparable or superior value — often at lower net cost, with no deductible on a layered structure, and access to a broad PPO network.
If your medication history is clean, there is nothing to prepare. If it is more complex, the single most valuable step is a conversation with a licensed producer before anything is submitted. A producer can review your Rx history with you, explain likely underwriting outcomes, and help you decide whether a private plan application makes sense — or whether the ACA marketplace is the right starting point.
No application is filed without your explicit approval. The review conversation costs nothing and eliminates the risk of a poorly structured application that comes back with a preventable rescission.
Review your medication list with a licensed producer before applying — no application is filed without your say-so.
Talk to a Licensed Producer